Your browser doesn't support javascript.
loading
A low-cost, open-source evolutionary bioreactor and its educational use.
Gopalakrishnan, Vishhvaan; Crozier, Dena; Card, Kyle J; Chick, Lacy D; Krishnan, Nikhil P; McClure, Erin; Pelesko, Julia; Williamson, Drew F K; Nichol, Daniel; Mandal, Soumyajit; Bonomo, Robert A; Scott, Jacob G.
Afiliação
  • Gopalakrishnan V; Lerner College of Medicine, Cleveland Clinic, Cleveland, United States.
  • Crozier D; Lerner College of Medicine, Cleveland Clinic, Cleveland, United States.
  • Card KJ; Case Western Reserve University School of Medicine, Cleveland, United States.
  • Chick LD; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, United States.
  • Krishnan NP; Hawken School, Gates Mills, United States.
  • McClure E; Case Western Reserve University School of Medicine, Cleveland, United States.
  • Pelesko J; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, United States.
  • Williamson DFK; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, United States.
  • Nichol D; Department of Physics, Case Western Reserve University, Cleveland, United States.
  • Mandal S; Department of Pathology, Massachusetts General Hospital, Boston, United States.
  • Bonomo RA; Department of Pathology, Brigham & Women's Hospital, Boston, United States.
  • Scott JG; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, United States.
Elife ; 112022 11 01.
Article em En | MEDLINE | ID: mdl-36317871
ABSTRACT
A morbidostat is a bioreactor that uses antibiotics to control the growth of bacteria, making it well-suited for studying the evolution of antibiotic resistance. However, morbidostats are often too expensive to be used in educational settings. Here we present a low-cost morbidostat called the EVolutionary biorEactor (EVE) that can be built by students with minimal engineering and programming experience. We describe how we validated EVE in a real classroom setting by evolving replicate Escherichia coli populations under chloramphenicol challenge, thereby enabling students to learn about bacterial growth and antibiotic resistance.
Assuntos
Palavras-chave

Texto completo: 1 Temas: ECOS / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Infecções por Escherichia coli Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Temas: ECOS / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Infecções por Escherichia coli Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos